Logo of Alcidion (ASX:ALC)Latest Alcidion (ASX:ALC) News

Page 1
Page 1 of 3

Alcidion posts record FY26 as shareholders approve 10-for-1 consolidation

Alcidion has entered FY27 with record contracted revenue, a debt-free balance sheet and reaffirmed guidance for revenue and underlying EBITDA to exceed FY26. Shareholders also approved a 10-for-1 share consolidation as the healthcare software company weighs buy-backs, acquisitions and further platform investment.
Victor Sage
12 Nov 2026

Alcidion turns 38% contracted revenue growth into a broader FY27 expansion push

Alcidion has started FY27 with contracted revenue up 38% to $50.0 million, while a major UK expansion and new patient administration product widen its growth case. The company has also reaffirmed that FY27 revenue and underlying EBITDA will exceed FY26, but its capital plan now has several competing demands.
Victor Sage
29 Oct 2026

Alcidion opens door to 135 million share buy-back

Alcidion will launch an on-market buy-back of up to 10% of its issued shares, giving the healthcare software company another way to deploy capital as cash generation improves. The maximum is a capacity, not a commitment, with purchases expected to be selective.
Victor Sage
27 Oct 2026

Alcidion signs A$7.5M Northern Care Alliance patient flow contract

Alcidion will roll out its Miya Flow software across four Northern Care Alliance hospitals under a new A$7.5 million contract. About A$4.5 million is expected to be recognised as revenue in the current year, including a six-month renewal of the existing ExtraMed system during implementation.
Victor Sage
30 Sept 2026

Alcidion Posts Record $7.7M Q4 Cashflow, Secures $43.2M in New Contracts

Alcidion delivered a record Q4 FY26 operating cashflow of $7.7 million and secured a $35 million UK contract, while completing a strategic acquisition that expands its ANZ footprint.
Victor Sage
23 July 2026

Healthcare Wrap - Week 27 (29 June -> 3 July) 2026

Cann Group, OncoSil and Imugene led a busy healthcare week as investors chased FDA steps, cancer trial news and balance-sheet fixes. Elsewhere, revenue growth, hospital contracts and fresh funding kept money flowing into names with near-term commercial milestones.
Logan Eniac
4 July 2026

Alcidion Reaffirms FY26 Targets as Kyra Acquisition Boosts Patient Flow Reach

Alcidion confirms FY26 revenue above $50 million and EBITDA over $5 million, completing the Kyra flow products acquisition from Telstra Health to expand its patient flow solutions in ANZ and the UK.
Ada Torres
29 June 2026

Healthcare Wrap - Week 22 (25 May -> 29 May) 2026

Biotech names led healthcare trading this week, with Noxopharm, Acrux and TruScreen posting the biggest moves after clinical, licensing and expansion updates. Stronger cash flow, fresh capital and new contracts also lifted sentiment across medtech, aged care and healthcare services.
Logan Eniac
30 May 2026

Alcidion Secures $35M UK EPR Contract with University Hospitals Sussex

Alcidion has landed a $35 million, seven-year contract to deploy its Miya Precision Electronic Patient Record platform at University Hospitals Sussex, marking a significant expansion in the UK healthcare IT market.
Ada Torres
25 May 2026

Healthcare Wrap - Week 21 (18 May -> 22 May) 2026

Imugene, Vitasora and Adherium led a volatile week in healthcare shares, as trial news and software rollouts battled capital raisings, legal issues and weak sentiment in smaller biotech names. Big contracts, takeover steps and record earnings kept the sector busy, but several stocks still fell even after reporting clear operational progress.
Logan Eniac
23 May 2026

Alcidion Expands Australian Patient Flow Footprint with $3M Kyra Acquisition

Alcidion Group has acquired Telstra Health's Kyra flow products for $3 million upfront, adding 33 long-term customers and boosting recurring revenue in key Australian states.
Ada Torres
18 May 2026

Alcidion Reports $1.7M Q3 Cashflow, Eyes May Signing for $35M UK EPR Deal

Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.
Victor Sage
29 Apr 2026